Search Results - "Tsonas, A. M."

Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study by Tsonas, A.M., van Meenen, D.M., Botta, M., Shrestha, G.S., Roca, O., Paulus, F., Neto, A.S., Schultz, M.J.

“…We determined the prevalences of hyperoxemia and excessive oxygen use, and the epidemiology, ventilation characteristics and outcomes associated with…”
Get full text

Practice of tracheostomy in patients with acute respiratory failure related to COVID–19 – Insights from the PRoVENT–COVID study by Tsonas, A.M., Botta, M., Horn, J., Brenner, M.J., Teng, M.S., McGrath, B.A., Schultz, M.J., Paulus, F., Serpa Neto, A.

“…Invasively ventilated patients with acute respiratory failure related to coronavirus disease 2019 (COVID–19) potentially benefit from tracheostomy. The aim of…”
Get full text

Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study by Schuijt, Michiel T. U., Schultz, Marcus J., Paulus, Frederique, Serpa Neto, Ary, van Akkeren, J. P., Algera, A. G., Algoe, C. K., van Amstel, R. B., Baur, O. L., van de Berg, P., Bergmans, D. C. J. J., van den Bersselaar, D. I., Bertens, F. A., Bindels, A. J. G. H., de Boer, M. M., Boer, S.den, Boers, L. S., Bogerd, M., Bos, L. D. J., Botta, M., Breel, J. S., de Bruin, H., de Bruin, S., Bruna, C. L., Buiteman-Kruizinga, L. A., Cremer, O., Determann, R. M., Dieperink, W., Dongelmans, D. A., Franke, H. S., Aldridge, M. S. Galek, de Graaff, M. J., Hagens, L. A., Haringman, J. J., Heijnen, N. F. L., Hiel, S., van der Heide, S. T., van der Heiden, P. L. J., Hoeijmakers, L. L., Hol, L., Hollmann, M. W., Hoogendoorn, M. E., Horn, J., van der Horst, R., Ie, E. L. K., Ivanov, D., Juffermans, N. P., Kho, E., de Klerk, E. S., Koopman, A. W. M., Koopmans, M., Kucukcelebi, S., Kuiper, M. A., de Lange, D. W., van Meenen, D. M., Martin-Loeches, Ignacio, Mazzinari, Guido, van Mourik, N., Nijbroek, S. G., Onrust, M., Oostdijk, E. A. N., Paulus, F., Pennartz, C. J., Pillay, J., Pisani, L., Purmer, I. M., Rettig, T. C. D., Roozeman, J. P., Schuijt, M. T. U., Schultz, M. J., Neto, A. Serpa, Sleeswijk, M. E., Smit, M. R., Spronk, P. E., Stilma, W., Strang, A. C., Tsonas, A. M., Tuinman, P. R., Valk, C. M. A., Veen, F. L., Vlaar, A. P. J., Veldhuis, L. I., van Velzen, P., van der Ven, W. H., van Vliet, P., van der Voort, P., van der Wier, H. H., van Welie, L., Wesselink, H. J. F. T., van Wijk, B., Winters, T., Wong, W. Y., van Zanten, A. R. H.

“…Abstract Background The intensity of ventilation, reflected by driving pressure (ΔP) and mechanical power (MP), has an association with outcome in invasively…”
Get full text

Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis by Ahuja, Sanchit, de Grooth, Harm-Jan, Paulus, Frederique, van der Ven, Fleur L, Serpa Neto, Ary, Schultz, Marcus J, Tuinman, Pieter R

“…Increasing evidence indicates the potential benefits of restricted fluid management in critically ill patients. Evidence lacks on the optimal fluid management…”
Get full text

The effect of immunosuppressive therapies on the endothelial host response in critically ill COVID-19 patients by Slim, M. A., Lim, E. H. T., van Vught, L. A., Boer, A. M. Tuip-de, Rademaker, E., Mulier, J. L. G. Haitsma, Engel, J. J., Pickkers, P., van de Veerdonk, F. L., Vlaar, A. P. J., Derde, L. P. G., Juffermans, N. P.

“…While several effective therapies for critically ill patients with COVID-19 have been identified in large, well-conducted trials, the mechanisms underlying…”
Get full text

ICONIC study-conservative versus conventional oxygenation targets in intensive care patients: study protocol for a randomized clinical trial by Grim, C C A, van der Wal, L I, Helmerhorst, H J F, van Westerloo, D J, Pelosi, P, Schultz, M J, de Jonge, E

“…Oxygen therapy is a widely used intervention in acutely ill patients in the intensive care unit (ICU). It is established that not only hypoxia, but also…”
Get full text

Prognostication using SpO 2 /FiO 2 in invasively ventilated ICU patients with ARDS due to COVID-19 - Insights from the PRoVENT-COVID study by Roozeman, Jan-Paul, Mazzinari, Guido, Serpa Neto, Ary, Hollmann, Markus W, Paulus, Frederique, Schultz, Marcus J, Pisani, Luigi

“…The SpO /FiO is a useful oxygenation parameter with prognostic capacity in patients with ARDS. We investigated the prognostic capacity of SpO /FiO for…”
Get full text

Endothelial Permeability and the Angiopoietin/Tie2 System Following Mild and Severe COVID-19 by Volleman, Carolien, Ibelings, Roselique, Vlaar, Alexander P. J., van den Brom, Charissa E.

“…Endotheliopathy plays a role in the development of acute kidney and lung injury in COVID-19, probably due to inflammation, endothelial permeability, vascular…”
Get full text